Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ZEISS Crossbeam Sets New Standards in 3D Nanotomography and Nanofabrication

Published: Tuesday, August 27, 2013
Last Updated: Tuesday, August 27, 2013
Bookmark and Share
Fast materials processing and high resolution imaging.

ZEISS will be presenting the first system of the new Crossbeam series at the MC 2013 in Regensburg, Germany.

Its outstanding features include high speed in materials analysis and processing and its wide diversity of applications.

Time intensive 3D experiments that used to run for several days can now be completed overnight.

The newly developed focused ion beam (FIB) column enables fast and precise materials processing that can be observed with the field emission scanning electron microscope in real-time.

High resolution over the entire voltage and current range allows users to work quickly and precisely. Designed for stability, the system ensures reproducible results even in long-term experiments.

The field of application is expanded by the optionally available Massive Ablation Laser that rapidly prepares samples to access deeply buried regions of interest. Crossbeam is suitable for use in both materials and life sciences.

Materials scientists benefit from the excellent 3D analytics, the ability to image magnetic and non-conductive specimens with maximum resolution, and from the unique material contrasts.

Bioscientists can use Crossbeam, above all, for fast tomography series with high Z resolution in cell and tissue biology. The STEM detection module delivers additional structural information.

The system offers automated workflows, e.g. for TEM lamella preparation. At the same time, the open software offers users the possibility of integrating and automating their own applications.

The modular design of Crossbeam makes it an open 3D nano workstation that can be configured and field-upgraded for a broad spectrum of today’s and future applications, therefore offering the user maximum flexibility.

The microscope system is available in two versions. The GEMINI I VP (variable pressure) column of Crossbeam 340 offers optimal analysis conditions for in situ experiments with outgassing and charging specimens.

Thanks to the GEMINI II column with double condenser system, Crossbeam 540 users benefit from more information in a shorter time.

The system delivers high resolution, even with low voltage and high beam current, enabling fast analytics and ease of use.

In combination with a ZEISS Xradia X-ray microscope (XRM), Crossbeam offers the possibility of complete specimen analysis across several orders of magnitude.

The X-ray microscope first provides a 3D image of the specimen without destroying it before the identified areas of interest are processed with the focused ion beam and analyzed with the electron beam.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Collaboration Between Carl Zeiss Microscopy and Gatan Announced
In situ ultramicrotome turns ZEISS FE-SEM into high speed 3D cell and tissue imaging system.
Monday, November 26, 2012
Carl Zeiss Nano Image Contest Off to a Successful Start
More than 70 users of ZEISS electron and ion microscopes have already submitted their nano masterpieces to the first ever Carl Zeiss Nano Image Contest.
Thursday, July 22, 2010
Carl Zeiss Still Committed to the Fight against Tuberculosis
Company announces special price for diagnostic microscope in 74 countries.
Tuesday, March 23, 2010
Carl Zeiss Microscopy Receives Fifth Consecutive R&D 100 Award
LSM 5 DUO – the Laser Scanning Microscope Awarded the "Oscar of Inventions".
Monday, July 24, 2006
PALM MicroBeam Laser Technology from Carl Zeiss Receives the Berthold Leibinger Innovation Prize
The Berthold Leibinger Innovation Prize is the international award for applied laser technology with the highest prize money.
Friday, July 14, 2006
Zeiss Optimises Axio Imager.A1
The Axio Imager.A1 incorporates an LED illumination system to boost the price/performance ratio.
Friday, February 10, 2006
Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!